SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-022689
Filing Date
2021-05-03
Accepted
2021-05-03 07:24:29
Documents
57
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q caba-10q_20210331.htm 10-Q 2081535
2 EX-10.1 caba-ex101_159.htm EX-10.1 42499
3 EX-31.1 caba-ex311_7.htm EX-31.1 20403
4 EX-31.2 caba-ex312_8.htm EX-31.2 20620
5 EX-32.1 caba-ex321_9.htm EX-32.1 10556
6 EX-32.2 caba-ex322_6.htm EX-32.2 10655
  Complete submission text file 0001564590-21-022689.txt   6162687

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT caba-20210331.xml EX-101.INS 1234266
8 XBRL TAXONOMY EXTENSION SCHEMA caba-20210331.xsd EX-101.SCH 41327
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE caba-20210331_cal.xml EX-101.CAL 29173
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE caba-20210331_def.xml EX-101.DEF 135771
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE caba-20210331_lab.xml EX-101.LAB 323918
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE caba-20210331_pre.xml EX-101.PRE 236684
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39103 | Film No.: 21881318
SIC: 2836 Biological Products, (No Diagnostic Substances)